Unihealth Hospitals Limited (NSE:UNIHEALTH)
167.50
+1.45 (0.87%)
At close: Jul 4, 2025
Unihealth Hospitals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
555.88 | 487.5 | 439.28 | 368.32 | 262.08 | Upgrade
| |
Revenue Growth (YoY) | 14.03% | 10.98% | 19.27% | 40.54% | 17.89% | Upgrade
|
Cost of Revenue | 212.02 | 168.22 | 151.85 | 150.43 | 111.39 | Upgrade
|
Gross Profit | 343.86 | 319.28 | 287.44 | 217.89 | 150.68 | Upgrade
|
Selling, General & Admin | - | 6.82 | 4.08 | 5.06 | 13.68 | Upgrade
|
Other Operating Expenses | 158.86 | 136.84 | 147.02 | 97.77 | 61.42 | Upgrade
|
Operating Expenses | 183.6 | 166.29 | 176.26 | 124.96 | 96.93 | Upgrade
|
Operating Income | 160.27 | 152.99 | 111.17 | 92.94 | 53.75 | Upgrade
|
Interest Expense | -15.58 | -22.24 | -38.93 | -49.71 | -8.9 | Upgrade
|
Interest & Investment Income | - | 13.79 | 5.63 | 3.52 | 0.05 | Upgrade
|
Earnings From Equity Investments | -0.21 | -0.81 | 0.02 | -0.76 | -0.3 | Upgrade
|
Currency Exchange Gain (Loss) | - | 1.54 | 12.13 | 5.33 | 8.24 | Upgrade
|
Other Non Operating Income (Expenses) | 28.15 | -9.66 | 2.77 | -1.67 | 0.77 | Upgrade
|
EBT Excluding Unusual Items | 172.62 | 135.6 | 92.8 | 49.66 | 53.62 | Upgrade
|
Pretax Income | 172.62 | 135.6 | 92.8 | 51.28 | 54.44 | Upgrade
|
Income Tax Expense | 21.37 | 32.56 | 16.21 | 14.11 | 5.24 | Upgrade
|
Earnings From Continuing Operations | 151.25 | 103.04 | 76.59 | 37.17 | 49.21 | Upgrade
|
Minority Interest in Earnings | 0.14 | 0.03 | 0.21 | 1.03 | 0.88 | Upgrade
|
Net Income | 151.4 | 103.07 | 76.8 | 38.2 | 50.09 | Upgrade
|
Net Income to Common | 151.4 | 103.07 | 76.8 | 38.2 | 50.09 | Upgrade
|
Net Income Growth | 46.89% | 34.20% | 101.04% | -23.73% | - | Upgrade
|
Shares Outstanding (Basic) | 15 | 13 | 11 | 11 | 11 | Upgrade
|
Shares Outstanding (Diluted) | 15 | 13 | 11 | 11 | 11 | Upgrade
|
Shares Change (YoY) | 14.55% | 21.47% | 0.00% | - | 3.10% | Upgrade
|
EPS (Basic) | 9.83 | 7.67 | 6.94 | 3.45 | 4.53 | Upgrade
|
EPS (Diluted) | 9.83 | 7.67 | 6.94 | 3.45 | 4.53 | Upgrade
|
EPS Growth | 28.23% | 10.48% | 101.12% | -23.76% | - | Upgrade
|
Free Cash Flow | -130.99 | 21.81 | -9.9 | 79.68 | 36.97 | Upgrade
|
Free Cash Flow Per Share | -8.51 | 1.62 | -0.89 | 7.20 | 3.34 | Upgrade
|
Gross Margin | 61.86% | 65.49% | 65.43% | 59.16% | 57.50% | Upgrade
|
Operating Margin | 28.83% | 31.38% | 25.31% | 25.23% | 20.51% | Upgrade
|
Profit Margin | 27.24% | 21.14% | 17.48% | 10.37% | 19.11% | Upgrade
|
Free Cash Flow Margin | -23.56% | 4.47% | -2.25% | 21.63% | 14.11% | Upgrade
|
EBITDA | 185.01 | 175.42 | 136.14 | 114.86 | 75.37 | Upgrade
|
EBITDA Margin | 33.28% | 35.98% | 30.99% | 31.18% | 28.76% | Upgrade
|
D&A For EBITDA | 24.74 | 22.43 | 24.97 | 21.92 | 21.62 | Upgrade
|
EBIT | 160.27 | 152.99 | 111.17 | 92.94 | 53.75 | Upgrade
|
EBIT Margin | 28.83% | 31.38% | 25.31% | 25.23% | 20.51% | Upgrade
|
Effective Tax Rate | 12.38% | 24.01% | 17.47% | 27.52% | 9.62% | Upgrade
|
Revenue as Reported | 584.13 | 503.53 | 460.3 | 379.27 | 286.35 | Upgrade
|
Advertising Expenses | - | - | - | 5.06 | 13.68 | Upgrade
|
Updated Nov 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.